Posted On: 07/30/2015 5:24:06 PM
Post# of 42
$OCLS at breakout. Pr $1.77
Website
U.S. dermatology and Latin American sales drive 37% product revenue growth
FDA 510k clearance for treatment of atopic dermatitis with a unique "no touch" spray gel
Cash as of June 30, 2015 of $8.8 million and debt free
Conference call begins at 4:30 p.m. EDT today
Shares Outstanding: 15.96M
Float: 15.52M
% Held by Insiders: 8.15%
% Held by Institutions: 10.70%
Shares Short (as of Jul 15, 2015): 1.81M
Short Ratio (as of Jul 15, 2015): 2.30
Short % of Float (as of Jul 15, 2015): 12.00%
Shares Short (prior month): 1.94M
Headlines
Website
U.S. dermatology and Latin American sales drive 37% product revenue growth
FDA 510k clearance for treatment of atopic dermatitis with a unique "no touch" spray gel
Cash as of June 30, 2015 of $8.8 million and debt free
Conference call begins at 4:30 p.m. EDT today
Shares Outstanding: 15.96M
Float: 15.52M
% Held by Insiders: 8.15%
% Held by Institutions: 10.70%
Shares Short (as of Jul 15, 2015): 1.81M
Short Ratio (as of Jul 15, 2015): 2.30
Short % of Float (as of Jul 15, 2015): 12.00%
Shares Short (prior month): 1.94M
Headlines
(0)
(0)
